Royal Bank of Canada’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,805
Closed -$10K 7569
2022
Q1
$10K Sell
8,805
-12,001
-58% -$13.6K ﹤0.01% 6488
2021
Q4
$52K Buy
20,806
+10,376
+99% +$25.9K ﹤0.01% 5828
2021
Q3
$53K Buy
10,430
+4,283
+70% +$21.8K ﹤0.01% 5613
2021
Q2
$51K Buy
6,147
+3,913
+175% +$32.5K ﹤0.01% 5538
2021
Q1
$19K Buy
2,234
+714
+47% +$6.07K ﹤0.01% 5969
2020
Q4
$16K Buy
1,520
+1,517
+50,567% +$16K ﹤0.01% 5625
2020
Q3
$0 Sell
3
-174
-98% ﹤0.01% 6522
2020
Q2
$3K Sell
177
-230
-57% -$3.9K ﹤0.01% 5752
2020
Q1
$7K Sell
407
-1,948
-83% -$33.5K ﹤0.01% 5454
2019
Q4
$58K Buy
2,355
+2,305
+4,610% +$56.8K ﹤0.01% 4796
2019
Q3
$1K Sell
50
-882
-95% -$17.6K ﹤0.01% 5893
2019
Q2
$12K Buy
932
+17
+2% +$219 ﹤0.01% 5142
2019
Q1
$11K Buy
915
+26
+3% +$313 ﹤0.01% 5092
2018
Q4
$5K Sell
889
-1,981
-69% -$11.1K ﹤0.01% 5338
2018
Q3
$31K Buy
2,870
+1,684
+142% +$18.2K ﹤0.01% 4860
2018
Q2
$16K Buy
1,186
+306
+35% +$4.13K ﹤0.01% 5074
2018
Q1
$16K Sell
880
-825
-48% -$15K ﹤0.01% 4937
2017
Q4
$22K Sell
1,705
-3,631
-68% -$46.9K ﹤0.01% 4821
2017
Q3
$102K Buy
5,336
+3,381
+173% +$64.6K ﹤0.01% 4287
2017
Q2
$29K Sell
1,955
-3,314
-63% -$49.2K ﹤0.01% 4653
2017
Q1
$90K Sell
5,269
-1,665
-24% -$28.4K ﹤0.01% 4172
2016
Q4
$83K Buy
6,934
+2,254
+48% +$27K ﹤0.01% 4233
2016
Q3
$46K Hold
4,680
﹤0.01% 4455
2016
Q2
$48K Sell
4,680
-152
-3% -$1.56K ﹤0.01% 4466
2016
Q1
$59K Buy
4,832
+94
+2% +$1.15K ﹤0.01% 4365
2015
Q4
$76K Sell
4,738
-1,385
-23% -$22.2K ﹤0.01% 4377
2015
Q3
$78K Buy
+6,123
New +$78K ﹤0.01% 4330
2015
Q2
Sell
-342
Closed -$6K 6186
2015
Q1
$6K Buy
342
+43
+14% +$754 ﹤0.01% 5248
2014
Q4
$6K Buy
+299
New +$6K ﹤0.01% 5171
2014
Q3
Sell
-13
Closed 5553
2014
Q2
$0 Sell
13
-9
-41% ﹤0.01% 5559
2014
Q1
$0 Buy
22
+4
+22% ﹤0.01% 5487
2013
Q4
$0 Sell
18
-171
-90% ﹤0.01% 5501
2013
Q3
$8K Buy
189
+72
+62% +$3.05K ﹤0.01% 4923
2013
Q2
$3K Buy
+117
New +$3K ﹤0.01% 4954